Product image of Imigran Novum (Sumatriptan) supplied by GNH India

Imigran Novum

Active Ingredient:
Sumatriptan
Origin:
EU

Imigran Novum (Sumatriptan)

Sumatriptan, the active ingredient in Imigran Novum, is a selective serotonin (5‑HT1B/1D) receptor agonist presented as an oral tablet for oral use. It is employed for the acute treatment of migraine attacks in adults.

GNH India supplies Imigran Novum as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Glaxosmithkline Ab

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Imigran Novum belongs to the triptan class and is used to treat migraine‑related disorders.

  • Migraine: aborts acute migraine attacks and relieves associated headache pain.
  • Cluster headache: provides relief of acute cluster headache episodes.
  • Acute headache of other vascular origin: may be used to treat short‑lasting vascular headaches when prescribed.

How It Works

  • Sumatriptan acts as an agonist at the 5‑HT1B and 5‑HT1D receptors located on intracranial blood vessels and sensory nerve endings. Activation of these receptors causes cranial vasoconstriction and inhibits the release of pro‑inflammatory neuropeptides, thereby terminating the cascade that generates migraine pain.

Side Effects

Common Side Effects

  • Chest discomfort or tightness
  • Tingling or numbness in the face or extremities
  • Nausea or upset stomach
  • Dizziness or light‑headedness
  • Fatigue or weakness
  • Dry mouth

Serious or Rare Side Effects

  • Coronary vasospasm or myocardial infarction
  • Serotonin syndrome, especially with other serotonergic drugs
  • Severe allergic reactions (anaphylaxis, angioedema)
  • Stroke or transient ischemic attack
  • Hypertension or hypertensive crisis
  • Severe arrhythmias

Precautions & Warnings

Before using Imigran Novum, consider the following precautions:

  • Cardiovascular disease: avoid if you have coronary artery disease, uncontrolled hypertension, or a history of myocardial infarction.
  • History of stroke or transient ischemic attack: use only under strict medical supervision.
  • Concomitant serotonergic agents: assess risk of serotonin syndrome when combined with SSRIs, SNRIs, or MAO inhibitors.
  • Pregnancy and lactation: safety not established; discuss risks with a healthcare professional.
  • Age considerations: use caution in elderly patients due to increased cardiovascular risk.
  • Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Avoid Interactions

Sumatriptan may interact with several drug classes.

Major Interactions (Avoid)

  • MAO inhibitors: increase risk of serotonin syndrome.
  • Other triptans or ergot alkaloids: may cause excessive vasoconstriction.
  • SSRIs, SNRIs, or other serotonergic agents: heightened serotonin toxicity.
  • Certain antihypertensives (e.g., ergot derivatives): additive vasoconstrictive effect.
  • Monoamine oxidase inhibitors (both reversible and irreversible).

Moderate Interactions (Monitor Closely)

  • CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may raise sumatriptan plasma levels.
  • Oral contraceptives: possible reduced efficacy of migraine relief.
  • Antihistamines or sedatives: may enhance dizziness or drowsiness.
  • Alcohol: can increase the likelihood of side effects.
  • Herbal supplements (e.g., St. John’s wort): potential serotonergic interaction.

Frequently Asked Questions

Imigran Novum contains sumatriptan, a triptan medication prescribed for the acute treatment of migraine attacks. It works to relieve headache pain, nausea, and sensitivity to light or sound when a migraine episode begins.

Sumatriptan binds to 5‑HT1B and 5‑HT1D receptors on cranial blood vessels and sensory nerves. This binding causes the vessels to constrict and blocks the release of inflammatory neuropeptides, interrupting the migraine cascade and reducing pain.

The specific dose of Imigran Novum is determined by the prescribing clinician based on the patient’s medical history, severity of migraine, and other individual factors. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for sumatriptan in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Imigran Novum.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Imigran Novum (sumatriptan) is a first‑line triptan, offering rapid relief for many migraine sufferers. Compared with non‑specific analgesics, triptans target serotonin receptors directly, often providing faster and more complete headache resolution, though they require cardiovascular screening before use.

Imigran Novum should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original blister pack, protect them from moisture and direct sunlight, and keep out of reach of children.

Imigran Novum is taken orally, usually with a glass of water. It can be taken with or without food, but patients should avoid excessive alcohol consumption around the time of dosing, as it may increase side‑effect risk.

Serious risks include coronary vasospasm, myocardial infarction, stroke, and serotonin syndrome, especially when combined with other serotonergic drugs. Patients should seek immediate medical attention if they experience chest pain, severe headache, or signs of an allergic reaction.

Imigran Novum is contraindicated in individuals with known hypersensitivity to sumatriptan, uncontrolled hypertension, recent myocardial infarction or stroke, and those taking ergot derivatives or monoamine oxidase inhibitors. A thorough medical assessment is required before prescribing.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Sumatriptan

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT